Literature DB >> 7708158

Intraventricular rupture of a purulent brain abscess: case report.

S M Zeidman1, F H Geisler, A Olivi.   

Abstract

The mortality of patients with brain abscesses has decreased significantly from 38% in the 1950s to 25% in the 1980s (P = 0.003, Fisher's exact test by decade of report; asymptotic P values based on chi 2 distribution with 3 degrees of freedom, 28 series, 2825 total patients). This decrease in mortality has been attributed to improved diagnostic imaging, the evolution of neurosurgical techniques and understanding of intracranial pressure pathophysiology, greater critical care understanding, and newer antibiotics. However, the mortality associated with the intraventricular rupture of brain abscesses (IVROBA) remained consistently high (at or above 80% once IVROBA was identified) throughout these decades. Although 129 cases (84.5% mortality, 20 survivors) of IVROBA were located in these series and an additional six case reports of survival after IVROBA were found in the literature, treatment advice and detailed clinical description of these surviving cases are sparse or absent. A case of IVROBA with good quality of survival is presented along with the aggressive five-component therapeutic plan used. The five components are: 1) open craniotomy with debridement of abscess cavity, 2) lavage of the ventricular system, 3) 6 weeks of intravenous antibiotics, 4) intraventricular gentamicin twice daily for 6 weeks, and 5) intraventricular drainage for 6 weeks.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7708158     DOI: 10.1227/00006123-199501000-00026

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  11 in total

Review 1.  Diagnosis and management of brain abscess and subdural empyema.

Authors:  Gary L Bernardini
Journal:  Curr Neurol Neurosci Rep       Date:  2004-11       Impact factor: 5.081

2.  Clinical features and predictive factors of intraventricular rupture in patients who have bacterial brain abscesses.

Authors:  Tsung-Han Lee; Wen-Neng Chang; Thung-Ming Su; Hsueh-Wen Chang; Chun-Chung Lui; Jih-Tsun Ho; Hung-Chen Wang; Cheng-Hsien Lu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09-29       Impact factor: 10.154

Review 3.  Nocardiosis in solid-organ transplant recipients: spectrum of imaging findings.

Authors:  J Bargehr; L Flors; C Leiva-Salinas; T R Flohr; R Sawyer; H Bonatti; K D Hagspiel
Journal:  Clin Radiol       Date:  2013-01-23       Impact factor: 2.350

4.  Gas-forming brain abscess caused by Klebsiella pneumoniae.

Authors:  Keun Tae Cho; Bong Jin Park
Journal:  J Korean Neurosurg Soc       Date:  2008-12-31

Review 5.  Systematic Review of Efficacy, Pharmacokinetics, and Administration of Intraventricular Aminoglycosides in Adults.

Authors:  Marlys LeBras; Ivy Chow; Vincent H Mabasa; Mary H H Ensom
Journal:  Neurocrit Care       Date:  2016-12       Impact factor: 3.210

Review 6.  Central nervous system infections: a critical care approach.

Authors:  W C Ziai; R G Geocadin
Journal:  Curr Neurol Neurosci Rep       Date:  2001-11       Impact factor: 6.030

7.  Successful neuroendoscopic treatment of intraventricular brain abscess rupture.

Authors:  Takafumi Nishizaki; Norio Ikeda; Shigeki Nakano; Takanori Sakakura; Masaru Abiko; Tomomi Okamura
Journal:  Clin Pract       Date:  2011-07-01

8.  Spontaneous intraventricular rupture of pyogenic brain abscess: A short series of three cases and review of literature.

Authors:  Amey R Savardekar; Rajesh Krishna; A Arivazhagan
Journal:  Surg Neurol Int       Date:  2016-12-05

9.  Good Outcomes with the Intraventricular Vancomycin Therapy in a Patient with Ruptured Brain Abscesses.

Authors:  Ninh Doan; Ha Nguyen; Li Luyuan; Saman Shabani; Michael Gelsomino; Vijay Johnson
Journal:  Asian J Neurosurg       Date:  2018 Apr-Jun

10.  Continuous intraventricular vancomycin for treatment of ventriculitis using IRRAflow®: A case report.

Authors:  Ryan M Hess; Asham Khan; Mallory Edwards; Adnan H Siddiqui; Elad I Levy
Journal:  Surg Neurol Int       Date:  2021-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.